Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Alloy Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Alloy Ventures

Alloy Ventures

Operating

Alloy Ventures: An early-stage venture capital firm investing in life sciences, IT, and cleantech.

Location
Palo Alto, CA, US
Founded
1996
Firm
Compare
Portfolio
Employees

Investments

Giga Omni Media
Giga Omni Media

Total Raised

$22M

Rounds

6

Series F$8MFebruary 2014
Series E$6MMay 2011
Series D$2.5MOctober 2010
Series C$4.5MOctober 2008
Scifiniti
Scifiniti

Total Raised

$26.5M

Rounds

4

Series B$10MJuly 2013
Series A$10.5MJune 2010
Genomatica
Genomatica

Total Raised

$340.3M

Rounds

10

Series D$41.5MAugust 2012
Series C$15MApril 2010
Siluria Technologies
Siluria Technologies

Total Raised

$150.7M

Rounds

7

Series C$30MJuly 2012
Series B$20MSeptember 2011
Series A$13.3MOctober 2010
Ensenda
Ensenda

Total Raised

$12.1M

Rounds

2

Series Unknown$1.8MJanuary 2012
Vivotech
Vivotech
Acquired

Total Raised

$81.6M

Rounds

8

Series C$24MJune 2011
Cameron Health
Cameron Health
Acquired

Total Raised

$233.5M

Rounds

6

Series F$107MMay 2011
Pacific Biosciences of California
Pacific Biosciences of California
Public

Total Raised

$2B

Rounds

12

Series F$109MJuly 2010
Series E$68MOctober 2009
Series E$100MJuly 2008
Integrating PV
Integrating PV

Total Raised

$8.5M

Rounds

1

Series A$8.5MMarch 2010
Standard BioTools
Standard BioTools
Public

Total Raised

$375.2M

Rounds

9

Series Unknown$7.5MNovember 2009
Cambrios Technologies
Cambrios Technologies

Total Raised

$81.1M

Rounds

9

Series D$14.5MNovember 2009
Synergeyes
Synergeyes

Total Raised

$51.8M

Rounds

6

Series C$13.3MFebruary 2009
KaloBios Pharmaceuticals
KaloBios Pharmaceuticals
Public

Total Raised

$56M

Rounds

5

Series D$20MSeptember 2008
Moxsie
Moxsie

Total Raised

$4.7M

Rounds

2

Series A$1MJune 2008
NovaSys Health
NovaSys Health

Total Raised

$49.5M

Rounds

1

Series Unknown$49.5MMay 2008
Novasys Medical
Novasys Medical
Acquired

Total Raised

$144.9M

Rounds

7

Series D$49.5MMay 2008